(Q35060278)

English

Anti-EphA2 antibodies decrease EphA2 protein levels in murine CT26 colorectal and human MDA-231 breast tumors but do not inhibit tumor growth

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Anti-EphA2 antibodies decrease EphA2 protein levels in murine CT26 colorectal and human MDA-231 breast tumors but do not inhibit tumor growth (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

David Kiewlich

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Jianhuan Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Cynthia Gross

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Wei Xia

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Brent Larsen

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Ronald R Cobb

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sandra Biroc

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Jian-Ming Gu

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Takashi Sato

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

David R Light

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Tara Heitner

11

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Joerg Willuda

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

David Vogel

13

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Felipe Monteclaro

14

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Andrzej Citkowicz

15

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Steve R Roffler

16

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Deborah A Zajchowski

17

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

18-30

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

CD13 (aminopeptidase N) can associate with tumor-associated antigen L6 and enhance the motility of human lung cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

EPHA2/EFNA1 expression in human gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

The role of ephrins and Eph receptors in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

EphA2 expression is associated with aggressive features in ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

Expression and functional effects of Eph receptor tyrosine kinase A family members on Langerhans like dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

Inhibition of tumor growth and angiogenesis by soluble EphB4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

EphB2 as a therapeutic antibody drug target for the treatment of colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

Mechanisms and functions of Eph and ephrin signalling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

The ephrins and Eph receptors in angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

High-throughput generation and engineering of recombinant human antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

Overexpression of protein tyrosine kinases in human esophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

LacZ inducible, antigen/MHC-specific T cell hybrids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

8 July 2018

EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

25 October 2018

Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

25 October 2018

Differential EphA2 epitope display on normal versus malignant cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

25 October 2018

Human dendritic cells express neuronal Eph receptor tyrosine kinases: role of EphA2 in regulating adhesion to fibronectin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

25 October 2018

Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

25 October 2018

Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

25 October 2018

Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

25 October 2018

Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

25 October 2018

Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

25 October 2018

EphA2 overexpression causes tumorigenesis of mammary epithelial cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

25 October 2018

Overexpression of the EphA2 tyrosine kinase in prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1584286

25 October 2018

Potentiation of radioimmunotherapy by inhibition of topoisomerase I

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multivalent antibody fragments with high functional affinity for a tumor-associated carbohydrate antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

E-cadherin regulates the function of the EphA2 receptor tyrosine kinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/16533422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1593/NEO.05544

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35060278&oldid=1395401214"